Related Experiment Videos
[Multifactor analysis: method and application for the selection of molecules in cardiovascular diseases]
1Direction Médicale RLC, Paris, France.
Therapie
|September 12, 1998
Summary
Decision analysis methods like ELECTRE help pharmaceutical firms formally select drug molecules. ELECTRE 1 identified five anti-hypertensive candidates, while ELECTRE 2 pinpointed a single optimal choice from nine options.
Area of Science:
- Decision analysis
- Pharmaceutical R&D
- Multicriterion decision making
Context:
- Selecting optimal drug molecules for licensing is challenging for pharmaceutical firms.
- Formalized decision-making processes are needed to navigate complex choices.
- Multicriterion analysis offers a structured approach to evaluate and rank potential drug candidates.
Purpose:
- To present the foundational principles of multicriterion analysis methods.
- To demonstrate the application of ELECTRE (ELimination Et Choix Traduisant la REalité) methods in pharmaceutical decision-making.
- To illustrate the selection of an anti-hypertensive molecule using weighted criteria.
Summary:
- This study applies multicriterion analysis, specifically ELECTRE 1 and ELECTRE 2, to a preselected group of nine anti-hypertensive molecules.
- Twelve distinct criteria with varying weights were utilized to evaluate and rank the molecules.
- ELECTRE 1 yielded a shortlist of five molecules, whereas ELECTRE 2 successfully identified a single optimal choice.
Impact:
- Provides a robust framework for formalizing complex drug selection processes in the pharmaceutical industry.
- Highlights the utility of ELECTRE methods in integrating qualitative and quantitative data for decision-making.
- Demonstrates a practical approach to optimizing the selection of cardiovascular drugs, potentially accelerating therapeutic advancements.